EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 4.0

Unapproved peptide therapies and dermatologic care: Ethical boundaries in a gray-market era

Tarek Zieneldien, Sophia Ma, Jane M Grant-Kels

JAAD International · 2026-12 · 29 · 79-80

DOI: 10.1016/j.jdin.2026.09.006 ↗

Kurz gefasst

Editorial in der Zeitschrift JAAD International, 2026-12. Verfasst von Tarek Zieneldien und 2 weiteren Autor:innen. Beteiligte Einrichtung: Johns Hopkins University School of Medicine, Baltimore, Maryland. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ethicsgray-market therapeuticsharm reductionmotivational interviewingonline health marketingpatient autonomypatient safetypeptide therapyself-administrationunapproved drugs

Autor:innen und Institutionen

  • Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Department of Dermatology, University of Connecticut School of Medicine, Farmington, Connecticut.
  • Department of Dermatology, University of Florida College of Medicine, Gainesville, Florida.

Zitieren

APA

Zieneldien, T., Ma, S., & Grant-Kels, J. M. (2026). Unapproved peptide therapies and dermatologic care: Ethical boundaries in a gray-market era. JAAD International, 29, 79-80. https://doi.org/10.1016/j.jdin.2026.09.006

Vancouver

Zieneldien T, Ma S, Grant-Kels JM. Unapproved peptide therapies and dermatologic care: Ethical boundaries in a gray-market era. JAAD International. 2026;29:79-80. doi:10.1016/j.jdin.2026.09.006

BibTeX
@article{Zieneldien2026,
  author = {Zieneldien, Tarek and Ma, Sophia and Grant-Kels, Jane M},
  title = {Unapproved peptide therapies and dermatologic care: Ethical boundaries in a gray-market era},
  journal = {JAAD International},
  year = {2026},
  volume = {29},
  pages = {79--80},
  doi = {10.1016/j.jdin.2026.09.006}
}
Kostenlos starten →